Fate Therapeutics
FATE
FATE
250 hedge funds and large institutions have $5.66B invested in Fate Therapeutics in 2021 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 96 increasing their positions, 73 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
6% less funds holding
Funds holding: 265 → 250 (-15)
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
24% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 51
Holders
250
Holding in Top 10
9
Calls
$18.9M
Puts
$10.6M
Top Buyers
| 1 | +$185M | |
| 2 | +$43.2M | |
| 3 | +$32.4M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$30.5M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
+$28.3M |
Top Sellers
| 1 | -$130M | |
| 2 | -$88.1M | |
| 3 | -$37.2M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$33.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$26.8M |